US · EVH
Evolent Health, Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Arlington, VA 22203
- Website
- evolenthealth.com
Price · as of 2025-12-31
$3.75
Market cap 376.91M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $15.52 | +313.87% |
| Intrinsic Value(DCF) | $1.43 | -61.87% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $81.03 | +2,060.75% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | $3.43 | $108.27 | |||
| 2014 | |||||
| 2015 | $10.18 | $6.79 | $41.14 | ||
| 2016 | $20.65 | $45.84 | $3.08 | $0.00 | $0.00 |
| 2017 | $15.60 | $39.71 | $15.17 | $1.23 | $0.00 |
| 2018 | $12.48 | $34.69 | $28.35 | $1.45 | $0.00 |
| 2019 | $7.94 | $15.38 | $3.87 | $0.00 | $0.00 |
| 2020 | $20.46 | $26.24 | $124.96 | $0.00 | $0.00 |
| 2021 | $28.88 | $67.64 | $2.97 | $0.69 | $0.00 |
| 2022 | $30.98 | $42.54 | $369.10 | $0.44 | $0.00 |
| 2023 | $34.32 | $183.77 | $1,024.72 | $0.00 | $0.00 |
| 2024 | $8.99 | $24.28 | $2,062.68 | $0.00 | $0.00 |
| 2025 | $3.58 | $15.52 | $6.58 | $0.00 | $81.03 |
AI valuation
Our deep-learning model estimates Evolent Health, Inc.'s (EVH) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $15.52
- Current price
- $3.75
- AI upside
- +313.87%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.43
-61.87% upside
Graham-Dodd
—
— upside
Graham Formula
$81.03
+2,060.75% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| EVH | Evolent Health, Inc. | $3.75 | 376.91M | +314% | -62% | — | +2,061% | -0.71 | 0.98 | 0.22 | -0.76 | -0.13 | -0.47 | 15.09% | -0.24% | -28.49% | -81.81% | -0.48% | -26.08% | 0.05 | -0.08 | 1.31 | 1.23 | 0.37 | 52593.00% | -2656.00% | -17759.00% | 1.16% | 0.10 | 0.52% | 2.72% | -1.90% | 194.02% | -62.28 | 58.08 | 0.15 | 0.25 |
| AMN | AMN Healthcare Services, … | $19.48 | 748.3M | +170% | -58% | — | — | — | 1.22 | 0.29 | 15.68 | — | -1.98 | 22.93% | 1.21% | -3.51% | 0.00% | 1.94% | 0.00% | 1.30 | 0.73 | 0.94 | 0.72 | 7.90 | -3558.00% | -849.00% | 1250.00% | 34.29% | 0.47 | 16.66% | 0.00% | — | 36.62% | 47.79 | 5.88 | 0.58 | 2.47 |
| AVBP | ArriVent BioPharma, Inc. … | $22.97 | 948.23M | — | — | — | — | -8.55 | 2.67 | — | -5.83 | -47.58 | 2.67 | 0.00% | — | — | -39.36% | -469.29% | -36.75% | 0.00 | — | 13.14 | 12.70 | 0.92 | 1797.00% | — | 2573.00% | -10.20% | -4.06 | -349.38% | 0.00% | 0.00% | 0.00% | -4.98 | -6.69 | — | 22.46 |
| BFLY | Butterfly Network, Inc. | $3.79 | 957.36M | +668% | -29% | — | — | -12.35 | 4.85 | 9.75 | -12.15 | — | 5.05 | 46.85% | -88.53% | -78.95% | -42.25% | -104.05% | -27.89% | 0.09 | -58.00 | 3.83 | 2.72 | 1.97 | -882.00% | 1896.00% | -6386.00% | -1.69% | -0.20 | -19.32% | 0.00% | 0.00% | 7.02% | -9.47 | -51.01 | 8.39 | 1.64 |
| HSTM | HealthStream, Inc. | $21.23 | 629.85M | +76% | -51% | -73% | -65% | 34.97 | 1.81 | 2.11 | 8.98 | — | 8.96 | 64.74% | 6.66% | 6.03% | 5.14% | 5.38% | 3.56% | 0.04 | — | 0.96 | 0.77 | -0.32 | -758.00% | 426.00% | 10203.00% | 9.30% | 0.51 | 20.08% | 0.58% | 20.30% | 5.26% | 29.61 | 10.05 | 1.97 | 3.35 |
| KURA | Kura Oncology, Inc. | $8.73 | 759.66M | — | — | — | — | -3.73 | 1.57 | 12.04 | 0.37 | — | 1.57 | 100.00% | -358.55% | -322.89% | -42.91% | 126.01% | -28.78% | 0.04 | -119.33 | 9.46 | 9.24 | 1.23 | -288.00% | — | -20708.00% | 20.63% | 1.71 | -87.30% | 0.00% | 0.00% | 28.94% | 0.32 | -0.46 | -1.15 | -0.24 |
| MGTX | MeiraGTx Holdings plc | $7.56 | 608.51M | +360% | -66% | — | — | -3.01 | 6.57 | 13.39 | -3.51 | -7.13 | 6.65 | 28.51% | -493.44% | -444.10% | -143.48% | -223.66% | -49.55% | 1.25 | -12.37 | 2.03 | 1.88 | 0.15 | 4228.00% | 13742.00% | -1282.00% | -24.57% | -1.72 | -149.07% | 0.00% | 0.00% | 0.00% | -2.60 | -3.90 | 12.82 | -3.93 |
| MYGN | Myriad Genetics, Inc. | $4.61 | 429.72M | +702% | -57% | — | — | — | 1.27 | 0.57 | -1.33 | — | 2.87 | 69.93% | -16.90% | -44.38% | 0.00% | -22.11% | 0.00% | 0.57 | -11.51 | 2.49 | 1.98 | -0.15 | 18085.00% | -156.00% | -10469.00% | 0.39% | 0.01 | 0.31% | 0.00% | — | 0.00% | -3.79 | 293.13 | 0.64 | -0.54 |
| NUTX | Nutex Health, Inc. | $110.46 | 657.71M | +54% | +232% | -47% | +806% | 2.39 | 1.56 | 0.47 | 3.53 | — | 1.95 | 40.89% | 27.22% | 10.87% | 91.70% | 29.91% | 18.09% | 2.33 | 6.55 | 2.08 | 1.99 | 2.00 | -19346.00% | 9380.00% | -35302.00% | 9.15% | 0.16 | 5.50% | 2.83% | 6.80% | 2.83% | 4.02 | 25.16 | 1.09 | 1.21 |
| PSNL | Personalis, Inc. | $9.06 | 804.57M | +263% | — | — | — | -9.95 | 3.10 | — | -8.46 | — | 3.10 | 0.00% | — | — | -35.02% | -152.75% | -26.89% | 0.12 | -429.55 | 6.76 | 6.46 | 1.30 | -3358.00% | -10000.00% | 6994.00% | -9.83% | -1.89 | -137.82% | 0.00% | 0.00% | 5.59% | -6.82 | -7.56 | — | 3.95 |
| REPL | Replimune Group, Inc. | $7.65 | 631.68M | — | — | — | — | -3.38 | 2.01 | — | -1.69 | — | 2.01 | 0.00% | — | — | -62.58% | -1380.14% | -47.60% | 0.18 | -33.15 | 7.95 | 7.82 | 0.14 | -525.00% | — | 409.00% | -23.79% | -3.08 | -1049.44% | 0.00% | 0.00% | 4.35% | -1.64 | -2.15 | — | 0.67 |
About Evolent Health, Inc.
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
- CEO
- Seth Barrie Blackley
- Employees
- 4.5K
- Beta
- 0.24
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.43 ÷ $3.75) − 1 = -61.87% (DCF, example).